DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Overview Fund Activity
Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

33 hedge funds and large institutions have $3.2M invested in Deep Medicine Acquisition Corp. Rights in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
–
Reduced
–
Closed
–
Calls
$336K
Puts
–
Net Calls
+$336K
Net Calls Change
+$336K

Top Buyers

1
MP
1
Mangrove Partners
Connecticut
$480K
2
CAC
2
Cowen and Company
New York
$346K
3
YCM
3
Yakira Capital Management
Connecticut
$240K
4
OCAM
4
Owl Creek Asset Management
New York
$240K
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$208K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
$11K +$11K +33,195 New
FLC
27
Fifth Lane Capital
Texas
$8K +$8K +25,000 New
BCM
28
Bluefin Capital Management
New York
$5K +$5K +14,975 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$5K +$5K +15,124 New
Jane Street
30
Jane Street
New York
$4K +$4K +11,818 New
TRCT
31
Tower Research Capital (TRC)
New York
$3K +$3K +9,792 New
AA
32
Ancora Advisors
Ohio
$2K +$2K +5,000 New
UBS Group
33
UBS Group
Switzerland
$1K +$1K +2,298 New
1
2